Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show Post author: Post published:April 23, 2024 Post category:uncategorized Tafenoquine, a prodrug that could fulfill the criteria for a mass eradication campaign. You Might Also Like Gene variant linked to higher risk of chronic rejection after lung transplant December 2, 2025 Early menopause linked to worse cognitive function in later life April 16, 2025 3D printing crafts cerebral cortex tissues: A breakthrough for brain injury treatment October 8, 2023
3D printing crafts cerebral cortex tissues: A breakthrough for brain injury treatment October 8, 2023